Publication | Closed Access

A Prospective Feasibility Trial Investigating the Use of the Impella 2.5 System in Patients Undergoing High-Risk Percutaneous Coronary Intervention (The PROTECT I Trial)

Percutaneous Coronary InterventionCardiovascular DiseasePatient SafetyClinical TrialsProspective Feasibility TrialAcute Myocardial InfarctionMedicineCardiologyImpella 2.5Coronary Artery DiseaseMyocardial Infarction